FSA Wealth Management’s Biogen BIIB Stock Holding History

FSA Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$48.2K	Hold	344	–	–	0.02%	159
2025 Q2	$43.2K	Hold	344	–	–	0.02%	164
2025 Q1	$47.1K	Hold	344	–	–	0.02%	155
2024 Q4	$52.6K	Sell	344 -40	-10%	-$6.75K	0.02%	147
2024 Q3	$74.4K	Buy	+384	New	+$80.3K	0.03%	119
2024 Q1	$74.2K	Hold	344	–	–	0.03%	108
2023 Q4	$89K	Buy	+344	New	+$84.5K	0.04%	86
2021 Q1	–	Sell	-350	Closed	-$86K	–	71
2020 Q4	$86K	Buy	+350	New	+$90.3K	0.04%	92
2020 Q3	–	Sell	-350	Closed	-$94K	–	94
2020 Q2	$94K	Hold	350	–	–	0.06%	82
2020 Q1	$111K	Hold	350	–	–	0.09%	72
2019 Q4	$104K	Buy	+350	New	+$97.1K	0.07%	85

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FSA Wealth Management's BIIB Position: Q3 2025 in Review

FSA Wealth Management held its Biogen (BIIB) position steady in Q3 2025 at 344 shares worth $48.2K. The position accounts for 0.02% of the portfolio, ranked #159.

FSA Wealth Management first reported a position in BIIB in Q4 2019 and has held it in 11 quarters since. The position peaked at $111K in Q1 2020. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

FSA Wealth Management held 344 shares of Biogen worth $48.2K as of Q3 2025.
FSA Wealth Management left its Biogen share count unchanged in Q3 2025.
Biogen made up 0.02% of FSA Wealth Management's portfolio in Q3 2025, its #159 holding.
FSA Wealth Management first reported a position in Biogen in Q4 2019 and has held it in 11 quarters since.
FSA Wealth Management's Biogen position peaked at $111K in Q1 2020.
905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.